Donnelly J, Budohoski KP, Smielewski P, Czosnyka M. Regulation of the cerebral circulation: bedside assessment and clinical implication. Crit Care. 2016;20:129.
Aiyagari V, Gorelick PB. Management of Blood Pressure for Acute and Recurrent Stroke. 2009;40:2251–2256.
Qureshi Al. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation. 2008;118:176–187.
Martin NA, Patwardhan RV, Alexander MJ, Africk CZ, Lee JH, Shalmon E, et al. Characterization of cerebral hemodynamic phases following severe head trauma: hypoperfusion, hyperemia and vasospasm. J Neurosurg. 1997;879–919.
Wahlgren NG, Macmohan DG, Wahlgren NG. Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischemic stroke. Cerebrovasc Dis. 1994; 4: 204–210.
Powrs WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients with Acute Ischemic Stroke. 2018;49:46–110
Steiner T, Al-Shahi Salman R, Beer R, Christensen H, Cordonnier C, Csiba L, et al. European stroke organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. int J stroke 2014; 9: 840–855.
Webb RK, van der walt JH, Runciman WB, Williamson JA, Cockings J, Russell WJ, et al. The Australian Incident Monitoring Study. Which monitor? An Analysis of 2000 incident reports. Anaesth Intensive Care. 1993; 21: 529–542.
Anderson CS, Huang Y, Arima H, Heeley E, Skulina C, Parsons MW, et al. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the intensive Blood Pressure reduction in acute cerebral Haemorrhage trial (interact). stroke 2010; 41: 307–312.
Hill DM, Muir WK. Should Blood Pressure Be Aggresively Lowered After Intracerebral haemorrhage? INTERACT II, 2013;44: 2951–2952.
Qureshi Ai, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, et al. Intensive Blood-Pressure lowering in Patients with acute cerebral Hemorrhage. N Engl J Med 2016; 375:1033–1043
Klauber MR, Marshall LF, Luerson TG, Frankowski R, Tabaddor K, Eisenberg HM. Determinants of head injury mortality: importance of the low risk patient. Neurosurg. 1989; 24:31–36.
Carney N, Totten AM, O'Reilly C, Ullman JS, Hawryluk GW, Bell MJ, et al. Guidelines for the Management of severe traumatic Brain injury, Fourth edition. Neurosurgery. 2017 ;80: 6–15.
Connolly ES, Jr., Rabinstein AA, Carhuapoma JR, Der-deyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart association/American stroke association. Stroke 2012; 43: 1711–1737.
Woodhouse L, Scutt P, Krishnan K, Berge E, Gommans J, Ntaios G, et al. Effect of hyperacute administration (within 6 hours) of transdermal glyceryl trinitrate, a nitric oxide donor, on outcome after stroke: subgroup analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) trial. Stroke 2015; 46: 3194–3201.
Eisenberg HM, Gary HE JR, Aldrich EF, Saydjari C, Turner B, Foulkes MA, et al. Initial CT findings in 753 patients with severe head injury. A report from the NIH Traumatic Coma Data Bank. J Neurosurg. 1990; 73: 688–698.
Bouma GJ, Muizelaar JP, Choi SC, Newlon PG, Young HF. Cerebral circulation and metabolism after severe traumatic brain injury: the elusive role of ischemia. J Neurosurg. Nov 1991;75(5):688–698. PMID:1919689.
Ankolekar S, Fuller M, Cross I, Renton C, Cox P, Sprigg N, et al. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in Hypertensive Stroke Trial. Stroke 2013; 44: 3120–3128.